Related Experiment Video
Updated: Jun 19, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Time in range and its association with sudomotor dysfunction in individuals with type 1 diabetes mellitus
Ismael A Quintal-Medina1, Rossy S López-Prieto1, Karen A Romero-Torres1
1Departamento de Endocrinología y Metabolismo. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Introduction:
Time in range (TIR), a novel metric to evaluate glycemic control, is relevant to predict microvascular complications of diabetes. Sudomotor dysfunction is among the earliest findings detectable in diabetic peripheral neuropathy (DPN). This study aimed to evaluate the relationship between TIR obtained from continuous glucose monitoring (CGM) and sudomotor function evaluated by SUDOSCAN in subjects with type 1 diabetes mellitus (T1DM).
Materials And Methods:
We enrolled 90 individuals with T1DM. All of them underwent SUDOSCAN and 14-day CGM. SUDOSCAN measured feet electrochemical skin conductance (FESC), and sudomotor dysfunction was defined as average FESC<70μS. Logistic regressions were applied to examine the independent association between TIR and glycated hemoglobin (HbA1c) and sudomotor function.
Results:
The overall prevalence of sudomotor dysfunction was 65.6%. Patients with sudomotor dysfunction showed a decreased level of TIR (53.3±17.4% vs 64.4±12.7%, P<.05). No significant differences in HbA1c were observed between the groups with and without sudomotor dysfunction (median 8.1% [65mmol/mol] vs 7.6% [60mmol/mol]; P=.094). Correlation analysis showed that the relationship between TIR and FESC was stronger than between HbA1c and FESC. Finally, logistic regression revealed that TIR was inversely associated with the risk of sudomotor dysfunction detected by SUDOSCAN (P<.05).
Conclusions:
TIR is a glycemic control target inversely associated with sudomotor dysfunction assessed by SUDOSCAN in T1DM regardless of HbA1c.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis